CBMG
Cellular Biomedicine Group, Inc.
CBMG
CBMG
Delisted
CBMG was delisted on the 19th of February, 2021.
43 hedge funds and large institutions have $71.7M invested in Cellular Biomedicine Group, Inc. in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
Holders
43
Holding in Top 10
–
Calls
$201K
Puts
$317K
Top Buyers
| 1 | +$1.01M | |
| 2 | +$531K | |
| 3 | +$345K | |
| 4 |
Two Sigma Investments
New York
|
+$341K |
| 5 |
JP Morgan Chase
New York
|
+$301K |
Top Sellers
| 1 | -$405K | |
| 2 | -$405K | |
| 3 | -$33.2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$16.5K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$7.82K |